Abstract
Aberrant replication causes cells lacking BRCA2 to enter mitosis with under-replicated DNA, which activates a repair mechanism known as mitotic DNA synthesis (MiDAS). Here, we identify genome-wide the sites where MiDAS reactions occur when BRCA2 is abrogated. High-resolution profiling revealed that these sites are different from MiDAS at aphidicolin-induced common fragile sites in that they map to genomic regions replicating in the early S-phase, which are close to early-firing replication origins, are highly transcribed, and display R-loop-forming potential. Both transcription inhibition in early S-phase and RNaseH1 overexpression reduced MiDAS in BRCA2-deficient cells, indicating that transcription-replication conflicts (TRCs) and R-loops are the source of MiDAS. Importantly, the MiDAS sites identified in BRCA2-deficient cells also represent hotspots for genomic rearrangements in BRCA2-mutated breast tumors. Thus, our work provides a mechanism for how tumor-predisposing BRCA2 inactivation links transcription-induced DNA damage with mitotic DNA repair to fuel the genomic instability characteristic of cancer cells.
Original language | English |
---|---|
Journal | Molecular Cell |
Volume | 82 |
Issue number | 18 |
Pages (from-to) | 3382-3397.e7 |
ISSN | 1097-2765 |
DOIs | |
Publication status | Published - 2022 |
Externally published | Yes |
Bibliographical note
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.Keywords
- Aphidicolin/pharmacology
- BRCA2 Protein/genetics
- Chromosome Fragile Sites/genetics
- DNA/genetics
- DNA Damage
- DNA Replication
- Genomic Instability
- Humans
- Mitosis/genetics